💪

Tesamorelin

Also known as: Egrifta

Well ResearchedGrowth Hormone OptimizationProvider Rx Required

How It Works

Synthetic GHRH analog. FDA-approved for HIV-associated lipodystrophy. Potent stimulator of endogenous GH production.

What It's Used For

Visceral fat reductionAnti-agingCognitive functionBody composition

Administration

Route: Subcutaneous injection
Typical Cycle: 26 weeks (FDA protocol), can be used longer under supervision

Safety & Side Effects

Possible Side Effects

  • Injection site reactions
  • Arthralgia
  • Peripheral edema
  • Paresthesia

Contraindications

  • Active cancer
  • Pregnancy
  • Pituitary pathology
  • Hypersensitivity

Research Summary

FDA-approved. Demonstrated significant reduction in visceral adipose tissue and improvement in lipid profiles. Emerging data on cognitive benefits (NCBI, 2023).

References

  • Falutz J et al. N Engl J Med. 2007
  • Stanley TL et al. Ann Intern Med. 2024

Legal & Availability

FDA-approved (prescription)

This peptide requires a prescription from a licensed provider.

Dosing Protocol

Standard: 2mg daily

Frequency: Daily

Timing: Morning or before bed

Notes: FDA-approved medication. Most studied GH secretagogue.

🔒

Unlock Full Dosing Protocol

Specific dosing, frequency, timing, cycling schedules, and stacking guidance are available with a BioRoot AI Pro subscription.

Stacks Well With

Full stacking protocols and cycling schedules available with Pro subscription.

Is Tesamorelin Right for You?

Our AI analyzes your symptoms, labs, and medical history to determine if this peptide fits your protocol — and at what dose.

Is Tesamorelin right for you?

Get a free personalized analysis based on your symptoms and goals — delivered to your inbox.

This information is for educational purposes only and is not medical advice. Do not use any peptide without consulting a qualified healthcare provider. BioRoot AI is a clinical decision support tool — not a medical provider.